|
US4820834A
(en)
|
1984-06-26 |
1989-04-11 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
US4735941A
(en)
|
1986-12-23 |
1988-04-05 |
Merck & Co., Inc. |
1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
|
|
EP0304223A3
(en)
|
1987-08-17 |
1990-10-24 |
Merck & Co. Inc. |
Beta-carbolines as cholecy-stokinin and gastrin antagonist
|
|
US5166151A
(en)
|
1988-03-25 |
1992-11-24 |
Merck & Co., Inc. |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
|
|
US5032604A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
|
CA2032427A1
(en)
|
1989-12-18 |
1991-06-19 |
Mark G. Bock |
Benzodiazepines analogs
|
|
CA2032226A1
(en)
|
1989-12-18 |
1991-06-19 |
Mark G. Bock |
Benzodiazepine analogs
|
|
US5324726A
(en)
|
1989-12-18 |
1994-06-28 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
US5041453A
(en)
|
1990-05-30 |
1991-08-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4
|
|
US5095031A
(en)
|
1990-08-20 |
1992-03-10 |
Abbott Laboratories |
Indole derivatives which inhibit leukotriene biosynthesis
|
|
CA2056809A1
(en)
|
1990-12-07 |
1992-06-08 |
Mark G. Bock |
Benzodiazepine analogs
|
|
US5206237A
(en)
|
1991-05-14 |
1993-04-27 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
US5185331A
(en)
|
1991-05-14 |
1993-02-09 |
Merck & Co., Inc. |
Triazolobenzodiazepines
|
|
EP0518484A3
(en)
|
1991-05-14 |
1993-03-17 |
Merck & Co. Inc. |
1,4-benzodiazepines condesed with 5- and 6-membered heterocyclic rings to treat anxiety, pain, pupil constriction, withdrawal-syndrome or oncologic disorders
|
|
US5210082A
(en)
|
1991-05-16 |
1993-05-11 |
Merck & Co., Inc. |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
|
|
CA2071092A1
(en)
|
1991-06-14 |
1992-12-15 |
Roger M. Freidinger |
1,4-benzodiazepines with 5-membered heterocyclic rings
|
|
EP0523845A3
(en)
|
1991-06-14 |
1993-11-18 |
Merck & Co Inc |
New benzodiazepine analogs
|
|
US5177071A
(en)
|
1991-06-17 |
1993-01-05 |
Merck & Co., Inc. |
1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder
|
|
MY110227A
(en)
|
1991-08-12 |
1998-03-31 |
Ciba Geigy Ag |
1-acylpiperindine compounds.
|
|
GB9117852D0
(en)
|
1991-08-19 |
1991-10-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
ES2121988T3
(es)
|
1992-01-23 |
1998-12-16 |
Toray Industries |
Derivado de morfinano y uso medicinal.
|
|
AU4028393A
(en)
|
1992-05-28 |
1993-12-30 |
Pfizer Inc. |
New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
|
|
ATE188379T1
(de)
|
1992-10-14 |
2000-01-15 |
Merck & Co Inc |
Fibrinogenrezeptor-antagonisten
|
|
NZ268969A
(en)
|
1993-07-23 |
1997-06-24 |
Toray Industries |
Morphinan derivatives and pharmaceutical compositions
|
|
WO1995009159A1
(en)
|
1993-09-28 |
1995-04-06 |
Otsuka Pharmaceutical Company, Limited |
Quinoxaline derivative as antidiabetic agent
|
|
GB9408577D0
(en)
|
1994-04-29 |
1994-06-22 |
Fujisawa Pharmaceutical Co |
New compound
|
|
FR2725985B1
(fr)
|
1994-10-21 |
1996-11-15 |
Adir |
Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2734814B1
(fr)
|
1995-05-31 |
1997-07-04 |
Adir |
Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
EP0862436A1
(en)
|
1995-10-19 |
1998-09-09 |
Merck & Co., Inc. |
16-substituted-6-aza-steroid 5-alpha-reductase inhibitors
|
|
US5821261A
(en)
|
1995-12-08 |
1998-10-13 |
Merck & Co., Inc. |
Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase
|
|
DE69732868T2
(de)
|
1996-11-25 |
2006-04-13 |
Toray Industries, Inc. |
Mittel gegen Juckreiz
|
|
AU7080298A
(en)
|
1997-04-25 |
1998-11-24 |
Takeda Chemical Industries Ltd. |
Triazine derivatives, their production and agrochemical composition
|
|
PT948965E
(pt)
|
1997-07-11 |
2004-08-31 |
Toray Industries |
Composicoes medicinais estaveis contendo um derivado de 4,5-epoximorfinano
|
|
WO1999005146A1
(en)
|
1997-07-25 |
1999-02-04 |
Toray Industries, Inc. |
Hyponatremia remedies
|
|
JP4359711B2
(ja)
|
1997-09-02 |
2009-11-04 |
東レ株式会社 |
薬物依存症治療薬
|
|
FR2778662B1
(fr)
|
1998-05-12 |
2000-06-16 |
Adir |
Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
WO1999059586A1
(en)
|
1998-05-19 |
1999-11-25 |
Regents Of The University Of California |
Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
|
|
JP2000053572A
(ja)
|
1998-08-11 |
2000-02-22 |
Toray Ind Inc |
ＯＲＬ１（ｏｐｉｏｉｄ ｏｒｐｈａｎ）受容体拮抗薬
|
|
EP1115731A2
(de)
|
1998-09-04 |
2001-07-18 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Neue pyranosen
|
|
ATE254105T1
(de)
|
1998-09-25 |
2003-11-15 |
Astrazeneca Ab |
Benzamid-derivate und ihre verwendung als cytokine inhibitoren
|
|
DE69926806D1
(de)
|
1998-12-18 |
2005-09-22 |
Bristol Myers Squibb Pharma Co |
N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
|
|
CA2348740A1
(en)
|
1998-12-23 |
2000-07-06 |
Ruth R. Wexler |
Thrombin or factor xa inhibitors
|
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
|
CN1204139C
(zh)
|
1999-08-24 |
2005-06-01 |
东丽株式会社 |
神经性疼痛治疗剂
|
|
JP2001163784A
(ja)
|
1999-12-06 |
2001-06-19 |
Toray Ind Inc |
角膜または結膜用止痒剤
|
|
CA2397575A1
(en)
|
2000-01-13 |
2001-07-19 |
Tularik Inc. |
Antibacterial agents
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
US6545152B1
(en)
|
2000-07-18 |
2003-04-08 |
Parker Hughes Institute |
R-isomers of nonnucleoside inhibitors
|
|
US8338442B2
(en)
|
2001-03-30 |
2012-12-25 |
Toray Industries, Inc. |
Remedies for psychoneurosis
|
|
JP4239592B2
(ja)
|
2001-05-08 |
2009-03-18 |
東レ株式会社 |
敗血症治療剤
|
|
SE0101978D0
(sv)
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
New compounds
|
|
MY130373A
(en)
|
2001-10-29 |
2007-06-29 |
Malesci Sas |
Linear basic compounds having nk-2 antagonist activity and formulations thereof
|
|
MXPA04010539A
(es)
|
2002-04-26 |
2005-01-25 |
Nippon Shinyaku Co Ltd |
Derivados de quinazolina y medicamentos que los contienen.
|
|
US20050203084A1
(en)
|
2002-05-22 |
2005-09-15 |
Jeong Jae U. |
Protease inhibitors
|
|
WO2004007459A2
(en)
|
2002-07-12 |
2004-01-22 |
Janssen Pharmaceutica N.V. |
Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor
|
|
JP2004083511A
(ja)
|
2002-08-28 |
2004-03-18 |
Yamanouchi Pharmaceut Co Ltd |
アクリルアミド誘導体
|
|
AU2003261756A1
(en)
|
2002-08-28 |
2004-03-29 |
Toray Industries, Inc. |
Acrylamide derivatives
|
|
CA2527934A1
(en)
*
|
2003-06-05 |
2004-12-16 |
Warner-Lambert Company Llc |
Tetrazol benzofurancarboxamides with p13k activity as therapeutic agents
|
|
WO2005004810A2
(en)
|
2003-07-02 |
2005-01-20 |
Merck & Co., Inc. |
Arylsulfonamide derivatives
|
|
GB0324498D0
(en)
|
2003-07-21 |
2003-11-26 |
Aventis Pharma Inc |
Heterocyclic compounds as P2X7 ion channel blockers
|
|
CA2536253A1
(en)
|
2003-08-20 |
2005-03-03 |
Vertex Pharmaceuticals Incorporated |
Aminofurazan compounds useful as protein kinase inhibitors
|
|
CA2542220A1
(en)
|
2003-10-22 |
2005-05-06 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
AU2004285053B2
(en)
|
2003-10-28 |
2010-10-21 |
Vertex Pharmaceuticals, Incorporated |
Benzimidazoles useful as modulators of ion channels
|
|
CA2544857A1
(en)
|
2003-11-20 |
2005-06-09 |
Eli Lilly And Company |
Vitamin d receptor modulators
|
|
UA89035C2
(ru)
|
2003-12-03 |
2009-12-25 |
Лео Фарма А/С |
Эфиры гидроксамовых кислот и их фармацевтическое применение
|
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
|
WO2005105780A2
(en)
|
2004-04-28 |
2005-11-10 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
|
US20060223849A1
(en)
|
2005-03-14 |
2006-10-05 |
Mjalli Adnan M |
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
|
|
ES2351665T3
(es)
|
2005-03-24 |
2011-02-09 |
Rottapharm S.P.A. |
Derivados de benzamidina para el tratamiento y la prevención de mucositis.
|
|
MX2007015726A
(es)
|
2005-06-09 |
2008-03-04 |
Vertex Pharma |
Derivados de indano como moduladores de canales ionicos.
|
|
WO2007026720A1
(ja)
|
2005-08-31 |
2007-03-08 |
Taisho Pharmaceutical Co., Ltd. |
縮環ピラゾール誘導体
|
|
US7897766B2
(en)
|
2005-09-23 |
2011-03-01 |
Abbott Laboratories |
Amino-aza-adamantane derivatives and methods of use
|
|
EP1934191B1
(en)
|
2005-10-12 |
2012-03-28 |
Vertex Pharmaceuticals, Inc. |
Biphenyl derivatives as modulators of voltage gated ion channels
|
|
EP2316829A1
(en)
|
2005-12-21 |
2011-05-04 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
AU2007227274A1
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1P receptor modulating compounds
|
|
TW200815351A
(en)
|
2006-05-02 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds
|
|
EP2051964A4
(en)
|
2006-07-28 |
2012-03-07 |
Univ Connecticut |
INHIBITORS OF FATTY ACID AMIDHYDROLASE
|
|
WO2008027483A1
(en)
|
2006-08-31 |
2008-03-06 |
Arena Pharmaceuticals, Inc. |
Benzofuran derivatives as modulators of the 5-ht2a receptor
|
|
AR063311A1
(es)
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
Compuestos organicos
|
|
PL2151240T3
(pl)
|
2007-04-24 |
2014-01-31 |
Toray Industries |
Środek terapeutyczny lub profilaktyczny przeciw dyskinezie
|
|
PT2151241E
(pt)
|
2007-04-26 |
2012-05-07 |
Toray Industries |
Preparação sólida estável compreendendo um derivado de 4,5-epoximorfinano
|
|
TWI519508B
(zh)
|
2007-06-12 |
2016-02-01 |
Achaogen Inc |
抗菌劑
|
|
CA2690410C
(en)
|
2007-06-12 |
2015-09-29 |
Provid Pharmaceuticals, Inc. |
Kinase inhibitors, compositions thereof, and methods of use therewith
|
|
PL2196206T3
(pl)
|
2007-10-05 |
2020-02-28 |
Toray Industries, Inc. |
Środek do łagodzenia problemów skórnych zawierający pochodną morfinanu lub jego farmakologicznie dopuszczalną kwasową sól addycyjną jako substancję czynną
|
|
CN101412692B
(zh)
|
2007-10-18 |
2012-10-17 |
中国科学院上海药物研究所 |
1-(3-氨基丙基)哌啶-4-氨基酰胺类化合物、其药物组合物及其制备方法和用途
|
|
MX2010007548A
(es)
|
2008-01-11 |
2010-11-25 |
Univ California |
Activadores de procaspasas 3, 6 y 7 efectoras.
|
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
|
CA2721060A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
JP2011520809A
(ja)
|
2008-05-05 |
2011-07-21 |
アムジエン・インコーポレーテツド |
γセクレターゼモジュレーターとしての尿素化合物
|
|
TWI392673B
(zh)
|
2008-08-27 |
2013-04-11 |
Calcimedica Inc |
調控細胞內鈣離子濃度之化合物
|
|
CN101712679B
(zh)
|
2008-10-08 |
2013-04-10 |
中国科学院上海药物研究所 |
一种酰胺类化合物、其药物组合物及其制备方法和用途
|
|
CA2740476C
(en)
|
2008-10-24 |
2016-04-05 |
Toray Industries, Inc. |
Stable tablet containing 4,5-epoxymorphinan derivative
|
|
WO2010050445A1
(ja)
|
2008-10-27 |
2010-05-06 |
武田薬品工業株式会社 |
二環性化合物
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
CA2750577A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
WO2010088574A1
(en)
|
2009-01-30 |
2010-08-05 |
Sirtris Pharmaceuticals, Inc. |
Azabenzimidazoles and related analogs as sirtuin modulators
|
|
SG174883A1
(en)
|
2009-03-27 |
2011-11-28 |
Presidio Pharmaceuticals Inc |
Fused ring inhibitors of hepatitis c
|
|
IN2012DN01983A
(https=)
|
2009-08-24 |
2015-07-24 |
Ascepion Pharmaceuticals Inc |
|
|
AU2011205283B2
(en)
|
2010-01-13 |
2014-07-10 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
PH12012501552A1
(en)
|
2010-01-29 |
2017-04-26 |
Toray Industries |
Therapeutic or prophylactic agent for biliary diseases
|
|
US20130165475A1
(en)
|
2010-09-01 |
2013-06-27 |
Ascepion Pharmaceuticals, Inc. |
Deuterium-enriched heterocyclic compounds as kinase inhibitors
|
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
|
CA2825165C
(en)
|
2011-01-31 |
2018-07-03 |
Toray Industries, Inc. |
Therapeutic or prophylactic agent for cachexia
|
|
WO2012107475A1
(en)
|
2011-02-10 |
2012-08-16 |
Syngenta Participations Ag |
Microbiocidal pyrazole derivatives
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
US9282738B2
(en)
|
2011-07-11 |
2016-03-15 |
Wisconsin Alumni Research Foundation |
Antimicrobial compositions and methods of use thereof
|
|
WO2013009810A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
WO2013009830A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
BR112014015308A8
(pt)
|
2011-12-23 |
2017-06-13 |
Novartis Ag |
compostos para inibição da interação de bcl2 com contrapartes de ligação
|
|
JP6207399B2
(ja)
|
2012-01-13 |
2017-10-04 |
日本ケミファ株式会社 |
Ｐ２ｘ４受容体拮抗剤
|
|
DE102012103405A1
(de)
|
2012-04-18 |
2013-10-24 |
Heinrich-Pette-Institut |
Desoxyhypusin-Synthase-Inhibitoren
|
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
EP3082805B1
(en)
|
2013-12-20 |
2020-02-05 |
Institute for Drug Discovery, LLC |
Substituted amino triazoles, and methods using same
|
|
KR20150136294A
(ko)
|
2014-05-27 |
2015-12-07 |
주식회사 레고켐 바이오사이언스 |
인자 ＸＩａ 억제 활성을 가지는 신규한 화합물
|
|
EP2993174A1
(en)
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridine derivatives and their use in therapy
|
|
TWI664166B
(zh)
|
2014-10-24 |
2019-07-01 |
日商小野藥品工業股份有限公司 |
Ｋｃｎｑ２至５通道活化劑
|
|
ES2942308T3
(es)
|
2015-04-21 |
2023-05-31 |
Allgenesis Biotherapeutics Inc |
Compuestos y su uso como inhibidores de BACE1
|
|
WO2017039318A1
(en)
|
2015-09-01 |
2017-03-09 |
Kainos Medicine, Inc. |
Benzimidazole derivatives for dna methylation inhibitors
|
|
US10858347B2
(en)
|
2015-12-31 |
2020-12-08 |
Karyopharm Therapeutics Inc. |
Multicyclic compounds and uses thereof
|
|
JP6943239B2
(ja)
|
2016-04-22 |
2021-09-29 |
小野薬品工業株式会社 |
Ｋｃｎｑ２〜５チャネル活性化剤
|
|
CN109311882B
(zh)
|
2016-05-04 |
2022-02-11 |
Bci制药公司 |
作为蛋白激酶抑制剂的腺嘌呤衍生物
|
|
WO2018165501A1
(en)
|
2017-03-10 |
2018-09-13 |
Lycera Corporation |
INDOLINYL SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATMENT OF DISEASE
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2019111225A1
(en)
|
2017-12-08 |
2019-06-13 |
Avaliv Therapeutics |
Compounds and methods for the treatment of non‑alcoholic steatohepatitis
|
|
GB201809050D0
(en)
|
2018-06-01 |
2018-07-18 |
E Therapeutics Plc |
Modulators of tryptophan catabolism
|
|
WO2020028515A1
(en)
|
2018-07-31 |
2020-02-06 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Neuroprotective disruption of kv2.1/syntaxin interaction by small molecules
|
|
TW202021956A
(zh)
|
2018-08-09 |
2020-06-16 |
美商奇尼塔公司 |
視黃酸誘導基因"rig-i"途徑之活化劑及其使用方法
|
|
EP3841221A4
(en)
|
2018-08-23 |
2022-06-08 |
Memorial Sloan-Kettering Cancer Center |
BIOMARKERS TO DETERMINE CANCER SENSITIVITY TO PI3K INHIBITORS
|
|
JP7541483B2
(ja)
|
2018-09-03 |
2024-08-28 |
日本ケミファ株式会社 |
糖尿病性末梢神経障害のための医薬
|
|
CN111039942B
(zh)
|
2018-10-12 |
2023-04-14 |
上海长森药业有限公司 |
含氮杂环类化合物，及其制备方法、药物组合物和应用
|
|
CA3136151A1
(en)
|
2019-04-12 |
2020-10-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof
|
|
CN112566905B
(zh)
|
2019-05-10 |
2024-07-30 |
上海海雁医药科技有限公司 |
取代的苯基丙烯基吡啶类衍生物，其制法与医药上的用途
|
|
US20240300939A1
(en)
|
2021-06-14 |
2024-09-12 |
Scorpion Therapeutics, Inc. |
Urea derivatives which can be used to treat cancer
|